(Q45139079)

English

Renin-angiotensin system blockade prevents the increase in plasma transforming growth factor beta 1, and reduces proteinuria and kidney hypertrophy in the streptozotocin-diabetic rat.

scientific article published in September 2004

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Renin-angiotensin system blockade prevents the increase in plasma transforming growth factor beta 1, and reduces proteinuria and kidney hypertrophy in the streptozotocin-diabetic rat. (English)

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

kidney hypertrophy

1 reference

based on heuristic

inferred from title

author name string

Arie Erman

1

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Semyon Veksler

2

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Uzi Gafter

3

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Geoffrey Boner

4

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Clara Wittenberg

5

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

David Jonathan van Dijk

6

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

publication date

1 September 2004

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Journal of the Renin-Angiotensin-Aldosterone System

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

146-151

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2004.032

21 January 2018

Insulin and losartan reduce proteinuria and renal hypertrophy in the pregnant diabetic rat

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2004.032

21 January 2018

Additive effect of ACE inhibition and angiotensin II receptor blockade in type I diabetic patients with diabetic nephropathy

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2004.032

21 January 2018

Add-on angiotensin receptor blockade with maximized ACE inhibition

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2004.032

21 January 2018

Randomised controlled trial of dual blockade of renin-angiotensin system in patients with hypertension, microalbuminuria, and non-insulin dependent diabetes: the candesartan and lisinopril microalbuminuria (CALM) study

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2004.032

21 January 2018

Dosing angiotensin II blockers—beyond blood pressure

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2004.032

21 January 2018

Effect of enalapril and losartan on the events that precede diabetic nephropathy in rats

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2004.032

21 January 2018

Add-on angiotensin II receptor blockade lowers urinary transforming growth factor-beta levels

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2004.032

21 January 2018

Add-on anti-TGF-beta antibody to ACE inhibitor arrests progressive diabetic nephropathy in the rat.

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2004.032

21 January 2018

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2004.032

21 January 2018

Effect of combining an ACE inhibitor and an angiotensin II receptor blocker on plasma and kidney tissue angiotensin II levels

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2004.032

21 January 2018

Dual blockade of the renin-angiotensin system versus maximal recommended dose of ACE inhibition in diabetic nephropathy

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2004.032

21 January 2018

Comparative effects of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on blood pressure and the kidney

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2004.032

21 January 2018

Changes of endothelin in streptozotocin-induced diabetic rats: effects of an angiotensin converting enzyme inhibitor, enalapril maleate

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2004.032

21 January 2018

Regulation of intrarenal angiotensin II in hypertension

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2004.032

21 January 2018

Comparisons in vitro, ex vivo, and in vivo of the actions of seven structurally diverse inhibitors of angiotensin converting enzyme (ACE).

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2004.032

21 January 2018

Identifiers

10.3317/JRAAS.2004.032

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45139079&oldid=1516442980"